To Kill a Microglia: A Case for CSF1R Inhibitors.

Trends Immunol

Department of Neurobiology and Behavior, University of California, Irvine, CA 92697, USA.

Published: September 2020

Microglia, the brain's immune sentinels, have garnered much attention in recent years. Researchers have begun to identify the manifold roles that these cells play in the central nervous system (CNS), and this work has been greatly facilitated by microglial depletion paradigms. The varying degrees of spatiotemporal manipulation afforded by such techniques allow microglial ablation before, during, and/or following insult, injury, or disease. We review the major methods of microglial depletion, including toxin-based, genetic, and pharmacological approaches, which differ in key factors including depletion onset, duration, and off-target effects. We conclude that pharmacological CSF1R inhibitors afford the most extensive versatility in manipulating microglia, making them ideal candidates for future studies investigating microglial function in health and disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484341PMC
http://dx.doi.org/10.1016/j.it.2020.07.001DOI Listing

Publication Analysis

Top Keywords

csf1r inhibitors
8
microglial depletion
8
kill microglia
4
microglia case
4
case csf1r
4
inhibitors microglia
4
microglia brain's
4
brain's immune
4
immune sentinels
4
sentinels garnered
4

Similar Publications

Inhibition of Bruton's tyrosine kinase restricts neuroinflammation following intracerebral hemorrhage.

Theranostics

January 2025

Department of Neurology, Tianjin Neurological Institute, Tianjin Institute of Immunology, State Key Laboratory of Experimental Hematology, International Joint Laboratory of Ocular Diseases, Ministry of Education, Haihe Laboratory of Cell Ecosystem, Laboratory of Post-Neuroinjury Neurorepair and Regeneration in Central Nervous System Tianjin & Ministry of Education, Tianjin Medical University General Hospital, Tianjin 300052, China.

Intracerebral hemorrhage (ICH) is a devastating form of stroke with a lack of effective treatments. Following disease onset, ICH activates microglia and recruits peripheral leukocytes into the perihematomal region to amplify neural injury. Bruton's tyrosine kinase (BTK) controls the proliferation and survival of various myeloid cells and lymphocytes.

View Article and Find Full Text PDF

Ethnopharmacological Relevance: Epimedium Tourn. ex L. is a traditional Chinese medicine used for thousands of years in China to treat forgetfulness.

View Article and Find Full Text PDF

Background: Glioblastoma (GBM) has a median survival of <2 years. Pexidartinib (PLX3397) is a small-molecule inhibitor of CSF1R, KIT, and oncogenic FTL3, which are implicated in GBM treatment resistance. Results from glioma models indicate that combining radiation therapy (RT) and pexidartinib reduces radiation resistance.

View Article and Find Full Text PDF
Article Synopsis
  • CSF1R inhibitors can deplete and rejuvenate microglia in the brain, potentially improving conditions like Alzheimer's disease (AD).
  • The study used 5xFAD mice to investigate how microglial depletion and repopulation affect amyloid plaque progression and found temporary improvements in plaque burden.
  • Although the improvements weren't lasting, renewing microglia late in disease progression may enhance their responsiveness to noradrenergic signaling, suggesting a possible therapeutic approach for AD.
View Article and Find Full Text PDF

A growing body of evidence highlights the importance of microglia, the resident immune cells of the CNS, and their pro-inflammatory activation in the onset of many neurological diseases. Microglial proliferation, differentiation, and survival are highly dependent on the CSF-1 signaling pathway, which can be pharmacologically modulated by inhibiting its receptor, CSF-1R. Pharmacological inhibition of CSF-1R leads to an almost complete microglial depletion whereas treatment arrest allows for subsequent repopulation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!